BACKGROUND: There are few recent studies of incident hepatitis C virus (HCV) infection among human immunodeficiency virus (HIV)-infected patients in the United States. METHODS: We studied HIV Outpatient Study (HOPS) participants seen in 9 HIV-specialty clinics who had ≥1 clinical encounter during 2000-2013 and ≥2 HCV-related tests, the first of which was a negative HCV antibody test (Ab). Hepatitis C virus incident cases were identified by first positive HCV Ab, viral load, or genotype. We assessed rates of incident HCV overall, by calendar intervals, and by demographic and HIV risk strata, and we explored risk factors for incident HCV using Cox proportional hazards models. RESULTS: The 1941 eligible patients (median age 40 years, 23% female, 61% men who had sex with men [MSM], and 3% persons who injected drugs [PWID]) experienced 102 (5.3%) incident HCV infections for an overall incidence of 1.07 (95% confidence interval [CI], 0.87-1.30) per 100 person-years (py). Hepatitis C virus incidence decreased from 1.83 in 2000-2003 to 0.88 in 2011-2013 (P = .024), with decreases observed (P < .05) among PWID and heterosexuals, but not among MSM. Overall, MSM comprised 59% of incident cases, and PWID were at most risk for incident HCV infection (adjusted hazard ratio [aHR] for PWID = 4.62 and 95% CI = 2.11-10.13; for MSM, aHR = 1.48 and 95% CI = 0.86-2.55 compared with heterosexuals). CONCLUSIONS: Among HIV-infected patients in care during 2000-2013, incidence of HCV infection exceeded 1 case per 100 py. Our findings support recommendations for annual HCV screenings for HIV-infected persons, including persons with only MSM risk, to enable HCV diagnosis and treatment for coinfected individuals.
BACKGROUND: There are few recent studies of incident hepatitis C virus (HCV) infection among human immunodeficiency virus (HIV)-infectedpatients in the United States. METHODS: We studied HIVOutpatient Study (HOPS) participants seen in 9 HIV-specialty clinics who had ≥1 clinical encounter during 2000-2013 and ≥2 HCV-related tests, the first of which was a negative HCV antibody test (Ab). Hepatitis C virus incident cases were identified by first positive HCV Ab, viral load, or genotype. We assessed rates of incident HCV overall, by calendar intervals, and by demographic and HIV risk strata, and we explored risk factors for incident HCV using Cox proportional hazards models. RESULTS: The 1941 eligible patients (median age 40 years, 23% female, 61% men who had sex with men [MSM], and 3% persons who injected drugs [PWID]) experienced 102 (5.3%) incident HCV infections for an overall incidence of 1.07 (95% confidence interval [CI], 0.87-1.30) per 100 person-years (py). Hepatitis C virus incidence decreased from 1.83 in 2000-2003 to 0.88 in 2011-2013 (P = .024), with decreases observed (P < .05) among PWID and heterosexuals, but not among MSM. Overall, MSM comprised 59% of incident cases, and PWID were at most risk for incident HCV infection (adjusted hazard ratio [aHR] for PWID = 4.62 and 95% CI = 2.11-10.13; for MSM, aHR = 1.48 and 95% CI = 0.86-2.55 compared with heterosexuals). CONCLUSIONS: Among HIV-infectedpatients in care during 2000-2013, incidence of HCV infection exceeded 1 case per 100 py. Our findings support recommendations for annual HCV screenings for HIV-infectedpersons, including persons with only MSM risk, to enable HCV diagnosis and treatment for coinfected individuals.
Entities:
Keywords:
HIV cohort; HIV/HCV coinfection; hepatitis C; incidence; risk factors.
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Jennifer R Kramer; Marc A Kowalkowski; Zhigang Duan; Elizabeth Y Chiao Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731
Authors: J Ghosn; C Deveau; C Goujard; I Garrigue; N Saïchi; J Galimand; Z Nagy; C Rouzioux; L Meyer; M-L Chaix Journal: Sex Transm Infect Date: 2006-08-21 Impact factor: 3.519
Authors: Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren Journal: Arch Intern Med Date: 2006 Aug 14-28
Authors: Philip R Spradling; James T Richardson; Kate Buchacz; Anne C Moorman; Lyn Finelli; Beth P Bell; John T Brooks Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: Suzanne M Ingle; Margaret T May; M John Gill; Michael J Mugavero; Charlotte Lewden; Sophie Abgrall; Gerd Fätkenheuer; Peter Reiss; Michael S Saag; Christian Manzardo; Sophie Grabar; Mathias Bruyand; David Moore; Amanda Mocroft; Timothy R Sterling; Antonella D'Arminio Monforte; Victoria Hernando; Ramon Teira; Jodie Guest; Matthias Cavassini; Heidi M Crane; Jonathan A C Sterne Journal: Clin Infect Dis Date: 2014-04-24 Impact factor: 9.079
Authors: Daniel Radwan; Edward Cachay; Oluwaseun Falade-Nwulia; Richard D Moore; Ryan Westergaard; William Christopher Mathews; Judith Aberg; Laura Cheever; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2019-04-15 Impact factor: 3.731
Authors: Jun Li; Carl Armon; Frank J Palella; Ellen Tedaldi; Richard M Novak; Jack Fuhrer; Gina Simoncini; Kimberly Carlson; Kate Buchacz Journal: Open Forum Infect Dis Date: 2021-04-17 Impact factor: 3.835
Authors: Kate Buchacz; Carl Armon; Frank J Palella; Richard M Novak; Jack Fuhrer; Ellen Tedaldi; Douglas Ward; Cynthia Mayer; Linda Battalora; Kimberly Carlson; Stacey Purinton; Marcus Durham; Jun Li Journal: Open Forum Infect Dis Date: 2020-04-11 Impact factor: 3.835
Authors: Antoine Chaillon; Xiaoying Sun; Edward R Cachay; David Looney; David Wyles; Richard S Garfein; Thomas C S Martin; Sonia Jain; Sanjay R Mehta; Davey M Smith; Susan J Little; Natasha K Martin Journal: Open Forum Infect Dis Date: 2019-04-03 Impact factor: 3.835
Authors: Phillip O Coffin; Glenn-Milo Santos; Emily Behar; Jaclyn Hern; John Walker; Tim Matheson; Elizabeth N Kinnard; Janelle Silvis; Eric Vittinghoff; Rena Fox; Kimberley Page Journal: PLoS One Date: 2019-06-03 Impact factor: 3.240